NCT04497584 2025-10-01
Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC
University of Texas Southwestern Medical Center
Phase 2 Active not recruiting
University of Texas Southwestern Medical Center
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Bristol-Myers Squibb